Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Hepatitis B |
|
|
Clinical Trial: Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
This study is currently recruiting patients.
|
Purpose
The objective of this study is to estimate the change in baseline serum Hepatitis C RNA levels among Latino and Caucasian patients to demonstrate that the response rate is not different.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hepatitis C | Drug: Pegylated Interferon alfa-2a (Pegasys) in combination with Ribavirin (Copegus) | Phase IV |
MedlinePlus related topics: Hepatitis C
Study Type: Interventional
Study Design: Treatment
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Infected with Hepatitis C virus
- Elevated ALT and AST levels
- Genotype 1
Exclusion Criteria:
- Previously treated with interferon/ribavirin
- NASH (nonalcoholic steatohepatitis)
- Positive for HIV
- Pregnancy
- Substance abuse
Location and Contact Information
Please reference Study ID Number: RLI-ML18179 973-235-5000
or 800-526-6367 (FOR US ONLY)
or 800-526-6367 (FOR US ONLY)
Arizona
Scottsdale, Arizona, 85259, United States; Not yet recruiting
Tucson, Arizona, 85712, United States; Recruiting
California
Anaheim, California, 92801, United States; Recruiting
Ventura, California, 93003, United States; Recruiting
San Bernadino, California, 92404, United States; Recruiting
San Diego, California, 92103, United States; Not yet recruiting
Redlands, California, 92373, United States; Recruiting
San Diego, California, 92161, United States; Not yet recruiting
Lancaster, California, 93534, United States; Recruiting
Stanford, California, 94305, United States; Recruiting
Fresno, California, 93702, United States; Not yet recruiting
Florida
Miami, Florida, 33136, United States; Recruiting
Miami, Florida, 33136, United States; Recruiting
North Miami, Florida, 33162, United States; Recruiting
Boca Raton, Florida, 33428, United States; Recruiting
Illinois
Chicago, Illinois, 60637, United States; Recruiting
Chicago, Illinois, 60612, United States; Recruiting
Indiana
Indianapolis, Indiana, 46202, United States; Recruiting
Louisiana
New Orleans, Louisiana, 70112, United States; Recruiting
Maryland
Baltimore, Maryland, 21205, United States; Not yet recruiting
Massachusetts
Framingham, Massachusetts, 01702, United States; Recruiting
Missouri
St. Louis, Missouri, 63110, United States; Recruiting
New York
Bayside, New York, 11358, United States; Recruiting
Brooklyn, New York, 11203, United States; Not yet recruiting
Setauket, New York, 11733, United States; Not yet recruiting
New York, New York, 10029, United States; Recruiting
Rochester, New York, 14642, United States; Recruiting
North Carolina
Chapel Hill, North Carolina, 27599, United States; Recruiting
Pennsylvania
Philadelphia, Pennsylvania, 19107, United States; Recruiting
Philadelphia, Pennsylvania, 19141, United States; Not yet recruiting
Texas
Galveston, Texas, 77555, United States; Not yet recruiting
Houston, Texas, 77030, United States; Recruiting
San Antonio, Texas, 78258, United States; Recruiting
Fort Sam Houston, Texas, 78234, United States; Recruiting
Forth Worth, Texas, 76107, United States; Not yet recruiting
Houston, Texas, 77030, United States; Recruiting
Puerto Rico
Santurce, 00909, Puerto Rico; Recruiting
More Information
Study ID Numbers: ML18179
Record last reviewed: April 2005
Last Updated: April 6, 2005
Record first received: April 6, 2005
ClinicalTrials.gov Identifier: NCT00107653
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: April 2005
Last Updated: April 6, 2005
Record first received: April 6, 2005
ClinicalTrials.gov Identifier: NCT00107653
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Add Hepatitis B Vaccination to Your Back to School List (National Center for Infectious Diseases, CDC, OPHS, HHS)
- Advice for Parents (Hepatitis B Foundation)
email this page
print this page
bookmark this page
feedback on this page
